Page 2 - Ib Communications News Today

Advances rollout of POCare Platform and POCare Therapies...

GERMANTOWN, Md., Oct. 30, 2023 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies , today announced that it has withdrawn its previously...

REGULATED INFORMATION Following the in-principle agreement reached with its main creditors in the context of ongoing equity raise process, the focus of BioSenic is now to proceed with fundraising, allowing to start its phase 3 international clinical trial with oral arsenic trioxide (ATO) in the first-line treatment of chronic Graft-versus-Host-Disease (cGvHD). Mont-Saint-Guibert, Belgium, October 25, 2023, 7.00 am CEST – BioSenic provides third quarter 2023 Business Update Following the i...

BioSenic performs further analysis of its phase 2 clinical trial data, leading to an optimal administration scheme for its next late-stage trial of arsenic trioxide in cGvHD New post-hoc analysis...

INSIDE INFORMATIONS BioSenic publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosis Arsenic trioxide therapeutic potential...

INSIDE INFORMATION New binding term sheets have been formulated upon for the replacement of the Monument and Patronale bonds and loans by new unsecured convertible bonds as well as for the long-term extension of the past loan financing with the European Investment Bank. Mont-Saint-Guibert, Belgium, September 14, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today ...

Information on the total number of voting rights and shares Mont-Saint-Guibert, Belgium, September 1, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and...

Reports Progress in Advancing the Rollout of the POCare Platform and POCare Therapeutic PipelineOrgenesis to Host Conference Call Today at 8:00 AM...

Name Change and Rebranding Reflects Progression of the Business and Focus on Changing the Paradigm of CGT Production GERMANTOWN, Md., July 11, 2023 (GLOBE…

INSIDE INFORMATION Agreement with the main creditors of BioSenic for a standstill running until October 2023 Mont-Saint-Guibert, Belgium, July 10th, 2023, 7.00 am CEST – BIOSENIC ,...